Moderna (MRNA) Enterprise Value (2016 - 2026)
Moderna (MRNA) reported Enterprise Value of -$5.2 billion for Q1 2026, up 12.89% year-over-year from -$4.6 billion in Q1 2025, and up 10.24% quarter-over-quarter from -$5.8 billion in Q4 2025.
Moderna (MRNA) Enterprise Value (2016 - 2026) Analysis & Trends
Moderna (MRNA) has 11 years of Enterprise Value data on file, last reported at -$5.2 billion in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$5.2 billion, up 12.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.2 billion (up 12.89% YoY), and the FY2025 annual result was -$5.8 billion, up 17.45% from the prior year.
- Enterprise Value advanced to -$5.2 billion in Q1 2026 per MRNA's latest filing, from -$5.8 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$4.5 billion in Q3 2025 and troughed at -$10.1 billion in Q1 2022.
- A 5-year average of -$7.5 billion and a median of -$7.9 billion in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value sank 30.77% in 2022, then surged 39.55% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$9.9 billion in 2022, then gained by 13.11% to -$8.6 billion in 2023, then gained by 18.35% to -$7.0 billion in 2024, then advanced by 17.45% to -$5.8 billion in 2025, then climbed by 10.24% to -$5.2 billion in 2026.
- Business Quant data shows MRNA's Enterprise Value at -$5.2 billion in Q1 2026, -$5.8 billion in Q4 2025, and -$4.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -5.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.21 Bn |
| Dec 31, 2025 | -5.80 Bn |
| Sep 30, 2025 | -4.50 Bn |
| Jun 30, 2025 | -5.13 Bn |
| Mar 31, 2025 | -5.98 Bn |
| Dec 31, 2024 | -7.03 Bn |
| Sep 30, 2024 | -6.87 Bn |
| Jun 30, 2024 | -8.49 Bn |
| Mar 31, 2024 | -8.52 Bn |
| Dec 31, 2023 | -8.60 Bn |
| Sep 30, 2023 | -7.57 Bn |
| Jun 30, 2023 | -8.46 Bn |
| Mar 31, 2023 | -8.92 Bn |
| Dec 31, 2022 | -9.90 Bn |
| Sep 30, 2022 | -8.35 Bn |
| Jun 30, 2022 | -7.90 Bn |
| Mar 31, 2022 | -10.12 Bn |
| Dec 31, 2021 | -10.73 Bn |
| Sep 30, 2021 | -8.91 Bn |
| Jun 30, 2021 | -7.99 Bn |